Fevzi Yalniz

Statistics

Publications

Citations

865

H-Index

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Mayo Clinic

Mayo Clinic in Florida

Mayo Clinic in Arizona

Levine Cancer Institute

Fevzi Yalniz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2012–2022

Publications

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Uri Greenbaum, Paolo Strati, Rima M. Saliba et al. · Blood Advances · 2021 · 146 citations · Full text

Veterinary Medicine, Hematology, Oncology +17

Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia

Ahmet Öztürk, Yaşar Küçükardalı, Alev Akyol Erikçi et al. · Journal of Diabetes and its Complications · 2012 · 104 citations

Medicine, Immunology, Surgery +9

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents

Matthieu Duchmann, Fevzi Yalniz, Alessandro Sanna et al. · EBioMedicine · 2018 · 82 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from <i>de novo</i> CMML

Mrinal M. Patnaik, Rangit Vallapureddy, Fevzi Yalniz et al. · American Journal of Hematology · 2017 · 59 citations · Full text

Medicine, Hematology, Oncology +17

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis

Fevzi Yalniz, M. Hassan Murad, Stephanie J. Lee et al. · Biology of Blood and Marrow Transplantation · 2018 · 58 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +11

1–5 of 18